Cite
Three-month sustained-release triptorelin (11.25 mg) in the treatment of central precocious puberty.
MLA
Carel, Jean-Claude, et al. “Three-Month Sustained-Release Triptorelin (11.25 Mg) in the Treatment of Central Precocious Puberty.” European Journal of Endocrinology, vol. 154, no. 1, Jan. 2006, pp. 119–24. EBSCOhost, https://doi.org/10.1530/eje.1.02056.
APA
Carel, J.-C., Blumberg, J., Seymour, C., Adamsbaum, C., & Lahlou, N. (2006). Three-month sustained-release triptorelin (11.25 mg) in the treatment of central precocious puberty. European Journal of Endocrinology, 154(1), 119–124. https://doi.org/10.1530/eje.1.02056
Chicago
Carel, Jean-Claude, Joëlle Blumberg, Christine Seymour, Catherine Adamsbaum, and Najiba Lahlou. 2006. “Three-Month Sustained-Release Triptorelin (11.25 Mg) in the Treatment of Central Precocious Puberty.” European Journal of Endocrinology 154 (1): 119–24. doi:10.1530/eje.1.02056.